Modulatory properties of curcumin in cancer: A narrative review on the role of interferons

被引:8
作者
Chamani, Sajjad [1 ,2 ]
Moossavi, Maryam [3 ]
Naghizadeh, Ali [1 ]
Abbasifard, Mitra [4 ,5 ]
Kesharwani, Prashant [6 ]
Sathyapalan, Thozhukat [7 ]
Sahebkar, Amirhossein [8 ,9 ,10 ]
机构
[1] Birjand Univ Med Sci BUMS, Med Toxicol & Drug Abuse Res Ctr MTDRC, Birjand, Iran
[2] Birjand Univ Med Sci, Fac Med, Dept Immunol, Birjand, Iran
[3] Birjand Univ Med Sci, Dept Mol Med, Birjand, Iran
[4] Rafsanjan Univ Med Sci, Res Inst Basic Med Sci, Immunol Infect Dis Res Ctr, Rafsanjan, Iran
[5] Rafsanjan Univ Med Sci, Ali Ibn Abi Talib Hosp, Sch Med, Dept Internal Med, Rafsanjan, Iran
[6] Sch Pharmaceut Educ & Res Jamia Hamdard, Dept Pharmaceut, New Delhi, India
[7] Univ Hull, Hull York Med Sch, Acad Diabet Endocrinol & Metab, Kingston Upon Hull, England
[8] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran
[9] Mashhad Univ Med Sci, Appl Biomed Res Ctr, Mashhad, Iran
[10] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran
关键词
cancer; curcumin; immunomodulation; turmeric; IN-VITRO; IL-2; ACTIVATION; POTENTIAL ROLE; RETINOIC ACID; NECK-CANCER; T-CELLS; KINASE; EXPRESSION; SUPPRESSES; MECHANISMS;
D O I
10.1002/ptr.7734
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The immune network is an effective network of cell types and chemical compounds established to maintain the body's homeostasis from foreign threats and to prevent the risk of a wide range of diseases; hence, its proper functioning and balance are essential. A dysfunctional immune system can contribute to various disorders, including cancer. Therefore, there has been considerable interest in molecules that can modulate the immune network. Curcumin, the active ingredient of turmeric, is one of these herbal remedies with many beneficial effects, including modulation of immunity. Curcumin is beneficial in managing various chronic inflammatory conditions, improving brain function, lowering cardiovascular disease risk, prevention and management of dementia, and prevention of aging. Several clinical studies have supported this evidence, suggesting curcumin to have an immunomodulatory and anti-inflammatory function; nevertheless, its mechanism of action is still not clear. In the current review, we aim to explore the modulatory function of curcumin through interferons in cancers.
引用
收藏
页码:1003 / 1014
页数:12
相关论文
共 124 条
[1]  
Abbas A.K., 2015, Cellular and Molecular Immunology, V8
[2]   Bioactive chemical constituents of Curcuma longa L. rhizomes extract inhibit the growth of human hepatoma cell line (HepG2) [J].
Abdel-Lateef, Ezzat ;
Mahmoud, Faten ;
Hammam, Olfat ;
El-Ahwany, Eman ;
El-Wakil, Eman ;
Kandil, Sherihan ;
Abu Taleb, Hoda ;
El-Sayed, Mortada ;
Hassenein, Hanaa .
ACTA PHARMACEUTICA, 2016, 66 (03) :387-398
[3]   Anti-tumor effects of Curcuminoids in Glioblastoma Multiforme : An Updated Literature Review [J].
Afshari, Amir R. ;
Jalili-Nik, Mohammad ;
Abbasinezhad-Moud, Farzaneh ;
Javid, Hossein ;
Karimi, Mohammad ;
Mollazadeh, Hamid ;
Jamialahmadi, Tannaz ;
Sathyapalan, Thozhukat ;
Sahebkar, Amirhossein .
CURRENT MEDICINAL CHEMISTRY, 2021, 28 (39) :8116-8138
[4]   Green tea polyphenols and their potential role in health and disease [J].
Afzal, M. ;
Safer, A. M. ;
Menon, M. .
INFLAMMOPHARMACOLOGY, 2015, 23 (04) :151-161
[5]  
Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1
[6]   Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IκBα kinase and Akt activation [J].
Aggarwal, S ;
Ichikawa, H ;
Takada, Y ;
Sandur, SK ;
Shishodia, S ;
Aggarwal, BB .
MOLECULAR PHARMACOLOGY, 2006, 69 (01) :195-206
[7]   Polyphenols and atherosclerosis: A critical review of clinical effects on LDL oxidation [J].
Ahmadi, Ali ;
Jamialahmadi, Tannaz ;
Sahebkar, Amirhossein .
PHARMACOLOGICAL RESEARCH, 2022, 184
[8]   Awareness and current knowledge of breast cancer [J].
Akram, Muhammad ;
Iqbal, Mehwish ;
Daniyal, Muhammad ;
Khan, Asmat Ullah .
BIOLOGICAL RESEARCH, 2017, 50
[9]   Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes [J].
Al-Ejeh, F. ;
Kumar, R. ;
Wiegmans, A. ;
Lakhani, S. R. ;
Brown, M. P. ;
Khanna, K. K. .
ONCOGENE, 2010, 29 (46) :6085-6098
[10]   A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas [J].
Alchanati, I. ;
Nallar, S. C. ;
Sun, P. ;
Gao, L. ;
Hu, J. ;
Stein, A. ;
Yakirevich, E. ;
Konforty, D. ;
Alroy, I. ;
Zhao, X. ;
Reddy, S. P. ;
Resnick, M. B. ;
Kalvakolanu, D. V. .
ONCOGENE, 2006, 25 (54) :7138-7147